Daré Bioscience, Inc.
DARE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $26,511 | $28,736 | $70,198 | $122,304 |
| - Cash | $15,698 | $10,476 | $34,670 | $51,674 |
| + Debt | $1,303 | $1,404 | $489 | $271 |
| Enterprise Value | $12,115 | $19,665 | $36,017 | $70,900 |
| Revenue | $10 | $2,808 | $10,000 | $0 |
| % Growth | -99.7% | -71.9% | – | – |
| Gross Profit | -$14,295 | -$18,830 | -$20,142 | -$100 |
| % Margin | -146,110.2% | -670.6% | -201.4% | – |
| EBITDA | -$23,409 | -$30,702 | -$31,361 | -$39,042 |
| % Margin | -239,259.6% | -1,093.4% | -313.6% | – |
| Net Income | -$4,054 | -$30,161 | -$30,948 | -$38,696 |
| % Margin | -41,430.9% | -1,074.2% | -309.5% | – |
| EPS Diluted | -0.48 | -4.15 | -4.39 | -7.52 |
| % Growth | 88.4% | 5.5% | 41.6% | – |
| Operating Cash Flow | $5,394 | -$38,857 | -$18,088 | -$28,764 |
| Capital Expenditures | -$573 | -$629 | -$63 | -$15 |
| Free Cash Flow | $4,821 | -$39,486 | -$18,151 | -$28,779 |